Clinical trial
Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study
NCT03446664 · LivaNova, Industry · Completed
Key facts
| NCT number | NCT03446664 |
|---|---|
| Title | Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study |
| Official title | Microburst VNS Therapy Feasibility Study in Subjects With Refractory Epilepsy |
| Acronym | Microburst |
| Lead sponsor | LivaNova, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Epilepsies, Partial, Epilepsy, Tonic-Clonic |
| Intervention type | Device |
| Interventions | Microburst Stimulation |
| Enrollment | 33 |
| Start date | Feb 27, 2018 |
| Primary completion | Jul 30, 2021 |
| Completion | Oct 27, 2021 |
| First posted | Feb 27, 2018 |
| Last update posted | Oct 25, 2022 |
| Countries | Belgium, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: